Upload
srdouthwaite
View
643
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Publications Powerhouse: Communications for your most precious assets, conducted with Precision, Integrity and Passion
Citation preview
AlphaBioComis the scientific communication
powerhouse that delivers your most precious assets
with precision, integrity, and passion
Confidential – Not for Distribution
• Global capability• US and UK facilities• Strength in experience• Exclusively in-house team
All have at least 4 years experience
All have PhDs Full service
• We create, refine and communicate value for your assets
Confidential – Not for Distribution
Inside AlphaBioCom
• Autoimmune Disease• Cardiovascular• Dermatology• Endocrinology• Gastroenterology• Genetics• Gynecology• Immunology• Infectious Disease• Metabolic
• Neuroscience/ Neuropsychology
• Obstetrics/Gynecology• Oncology• Pain Management• Pulmonology/
Respiratory Disease• Renal and Urology• Rheumatology• Virology
Confidential – Not for Distribution
Therapeutic Expertise
Experience Across the Product Life Cycle
• CERVISTA• CERVARIX• ULORIC• LA HPV TEST• MENHIBRIX• MONOPREP• RESLIZUMAB• IXIARO
• ORALGAM• ACHN-490• MENHIBRIX• Nano Assets
• ADIANA• NOVASURE• CERVISTA• CERVARIX• ULORIC• HAVRIX• PEDIARIX• TWINRIX• CERVISTA• OPTAFLU• FLUAD• AVODART
• ORALGAM • ACHN-490• ACHN-750• ACHN ESA• Nano assets
• AVODART• ADIANA• BACTROBAN• NOVASURE• CERVISTA• CERVARIX• FLUVIRIN• PEDIARIX• IXIARO• TWINRIX• HAVRIX• NAPROXEN• DICLOFENAC• INDOCIN • ULORIC• RYTHMOL SR• ALTABAX• LOVAZA
Phase I Phase II Phase IVProduct LaunchPhase III
Confidential – Not for Distribution
Experience into our 7th Year
Confidential – Not for Distribution
Scientific communication planning
Scientific communication development and execution
Thought Leader identification and engagement
Scientific Communication Service
• Systematic approach to ensuring that you reach your audience with the right data, information at the right time with the right frequency to create a change in understanding and/or awareness– AlphaBioCom
Scientific communication planning?
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Planning cycle
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
• Visualize, characterize and state the shift that you aim to create
Objectives
Awareness Beliefs Knowledge
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
• Intelligent Approach– Understanding and managing Issues
and Objectives• Driven by advanced SWOT analysis• Affirmative issues to assert advantages• Barriers and disadvantages to weigh
and balance– Route to success• Clear defined roadmap to achieve goals
Strategy
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Audience
How do we define and describe
them?
How do we communicate with them?
How will we know we have
communicated effectively?
Who do we need to communicate
with?
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Scientific Message
Tier1
Tier 2
Tier 3
• Core communication points
• Primary scientific evidence
• Evidence based medicine
• Health Economics and Outcomes Research
• Benefits and attributes from literature.
• Reviews and supporting clinical trials
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Journals
Impact
Specialty
Time
Acceptance
Congresses
Time
Audience
Acceptance
Interactive tools
On-Line Journals
Web based interactive
publications
Interruptive mediaCompany Apps
Scientific Channel Considerations
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Review and refine
Execute deliverables in line with plan framework
Populate content and finalize plan
Research authors
Identify plan framework
Delve into science
Situation analysis
Execution
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
• Strict adherence to policies• Clear defined training and QA procedures• Proven development processes
– Abstracts– Posters– Oral presentations– Manuscripts
• Data Management and Integrity – Communications trail– Audited processes
• Precise project reporting
• How do you manage these processes?
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Precision Processes
What•results versus objectives•milestones versus plans
When•cyclical
•before •during•after
How•set and measure key
performance indicators
Planning & Measurement
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Confidential – Not for Distribution
ID Task NameDuratio
nStart Finish Jan Feb
March
April May June July
1 Program106 days
Wed Jan 28, ‘09 Wed Jan 24, ‘09
2 Research 10 days Wed Jan 28, ‘09 Tues Feb 10, ’09
3Call w/ author and create outline
5 daysWed Feb 11, ‘09
Tues Feb 17, ’09
4 Expanded outline to client 15 daysWed Feb 18, ’09
Tues Mar 10, ’09
5 Client comments on outline 10 daysWed Mar 11, ’09
Tues Mar 24, ’09
6Expanded outline to authors
10 daysWed Mar 25, ’09
Tues April 7, ’09
7 Authors comments to ABC 10 daysWed April 8, ’09
Tues April 21, ’09
8Client comments on 1st draft to ABC
5 daysWed April 22, ’09
Tues April 28, ’09
9 Draft 1 to author 10 daysWed April 29, ’09
Tues May 12, ’09
10 Author review of Draft 1 10 daysWed May 13, ’09
Tues May 26, ’09
11Draft 2 to authors and Client
5 daysWed May 27, ’09
Tues Jun 2, ‘09
12 All comments due to ABC 5 days Wed Jun 3, ’09 Tues Jun 9, ‘09
13Final draft to authors and Client
5 days Wed Jun 10, ’09 Tues Jun 16, ‘09
14All comments and final approval due
5 days Wed Jun 17, ’09 Tues Jun 23, ‘09
15 Submission 1 day Wed Jun 24, ‘09 Wed Jun 24, ‘09
Writer
Writer
Writer
Writer
Writer
Writer
Writer
Author/Writer
Author
Author
Client/Author
Client/Author
Client
Client
Planning & Measurement
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
Project #Project Name
StartEstimated
FinishStatu
sVariance Comments
ADV01 Case Study 12/27/09 3/13/10 On Track Waiting for data
ADV02Abstract
PKPD11/23/09 1/10/10 +10 days
Awaiting data from Clinical
ADV03 Symposia 12/3/09 5/9/10 +5 daysFaculty
presentation catch up plan in place
ADV04Primary
Manuscript12/6/09 6/20/10 On Track
On target for first draft
ADV05 Ad Board 3/16/10 10/23/10 On TrackCreating advisor
list
On TrackVariance +/- 5 days
CautionVariance 5-10 days off
Off TrackVariance + 10 days
Confidential – Not for Distribution
Planning & Measurement
Strategy
Audience
Messages
Channels
Execution
Measurement
Objectives
AlphaBioCom broadest publication experience• Published in over 100 journals• Across 20 different
therapeutic categories• Spanning US, Eu and
International journals• Working with more 500
authors • Located in 10 different
countries
• Yet we demand that every single paper receives the same precision, integrity and passion as our first!
Publication Powerhouse
Our Clients
Confidential – Not for Distribution
Clients ….Partners
•19 plansScientific Communication Plans
•>250 scientific manuscripts
•>100 congress submissions (abstracts, posters)
•>200 scientific presentations
Scientific Communication
Deliverables
•70 advisory boards
•25 TL education programs
TL/KOL
Precision, Integrity and Passion in our 7th year
•100% approved and implemented
Scientific Communication Plans
•>90% acceptance first journal submitted
•100% all journal submissions
•>98% acceptance first congress
Scientific Communication
Deliverables
Performance Indicators: Precision, Integrity and Passion in numbers.
• Zero manuscripts rejected due to poor quality writing
• Never cited for inaccuracies or data management error by any client
• Never cited for a process compliance issue by any client
• Never had to withdraw any deliverable due to error
• Never failed a client audit• Zero citations in any newspaper
• Evidence our processes are robust and work
Power in the Negative
Contact Information
Stephen DouthwaitePresident and Chief Strategist
2 Radnor Corporate Center, Suite 200100 Matsonford Road
Radnor, PA 19087(610) 225-0400
Confidential – Not for Distribution